首页|他汀类药物联合曲美他嗪对冠心病心绞痛患者血管内皮功能及心绞痛发作的影响

他汀类药物联合曲美他嗪对冠心病心绞痛患者血管内皮功能及心绞痛发作的影响

扫码查看
目的 探究他汀类药物联合曲美他嗪对冠心病心绞痛患者血管内皮功能及心绞痛发作的影响.方法 选择2022 年 3 月—2023 年 3 月寿光市人民医院收治的 90 例冠心病心绞痛患者为研究对象,按随机数字表法分为对照组和观察组.对照组(n=45)采用阿托伐他汀片联合常规治疗,观察组(n=45)采用常规治疗、盐酸曲美他嗪缓释片联合阿托伐他汀片治疗.对比两组患者的心功能、血管内皮功能、心绞痛发作情况及不良反应发生情况.结果 治疗后,观察组的血清一氧化氮水平高于对照组,血清内皮素-1 及外周血循环内皮微颗粒水平均低于对照组,组间差异有统计学意义(P<0.05).治疗后,观察组的心绞痛发作次数少于对照组,心绞痛持续时间短于对照组,组间差异有统计学意义(P<0.05).治疗后,观察组的左室射血分数高于对照组,左室舒张末期内径短于对照组,心肌耗氧量低于对照组,组间差异有统计学意义(P<0.05).两组的不良反应发生率比较,差异无统计学意义(P>0.05).结论 采用他汀类药物联合曲美他嗪治疗冠心病心绞痛患者,能提升其血管内皮功能及心功能,改善心绞痛症状,安全性较佳.
Effects of Statins Combined with Trimetazidine on Vascular Endothelial Function and Angina Attacks in Patients with Coronary Heart Disease and Angina Pectoris
Objective To investigate the effects of statin combined with trimetazidine on vascular endothelial function and angina attacks in patients with coronary heart disease and angina pectoris.Methods 90 patients with coronary heart disease and angina pectoris admitted to the Shouguang People's Hospital from March 2022 to March 2023 were selected as the research subjects and were divided into a control group and an observation group according to random number table method.The control group(n=45)was treated with atorvastatin tablet combined with conventional treatment,and the observation group(n=45)was treated with conventional treatment,trimetazidine hydrochloride sustained-release tablet and atorvastatin tablet.The cardiac function,vascular endothelial function,angina pectoris attack and adverse reactions were compared between the two groups.Results After treatment,the serum nitric oxide level in the observation group was higher than that in the control group,and the serum endothelin-1 and peripheral blood circulating endothelial microparticles levels were lower than those in the control group,the differences between the groups were statistically significant(P<0.05).After treatment,the frequency of angina pectoris in the observation group was less than that in the control group,and the duration of angina pectoris was shorter than that in the control group,and the differences between the groups were statistically significant(P<0.05).After treatment,the left ventricular ejection fraction of the observation group was higher than that of the control group,the left ventricular end-diastolic diameter was shorter than that of the control group,and the myocardial oxygen consumption was lower than that of the control group,and the differences between the two groups were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Statins combined with trimetazidine in the treatment of patients with coronary heart disease and angina pectoris can improve the vascular endothelial function and cardiac function,improve the symptoms of angina pectoris,and the safety is better.

Coronary heart diseaseAngina pectorisStatinsTrimetazidineVascular endothelial functionAngina attacks

张晓莹、付瑞萍

展开 >

寿光市人民医院急诊科,山东潍坊 262700

寿光市人民医院内分泌科,山东潍坊 262700

冠心病 心绞痛 他汀类药物 曲美他嗪 血管内皮功能 心绞痛发作

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(6)
  • 8